mod 5

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/34

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 4:12 AM on 9/27/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

35 Terms

1
New cards

On average, how much does it cost to make a new drug?

$1.3 billion

2
New cards

How many phases are there for human testing?

4 phases

3
New cards

What is the gold standard for testing?

RCTs (Randomized controlled trials)

4
New cards

What is the first round of testing?

preclinical trials

5
New cards

What are pre-clinical trials?

Medicine/drug trials done on animals, cells or tissues

6
New cards

What is determined during pre-clinical trials?

cancer causing, gene mutations, or fertility issues

7
New cards

What section of the drug label includes nonclinical toxicology information?

13.1

8
New cards

What comes after pre-clinical trials?

IND (investigational new drug application)

9
New cards

Where does the IND go?

to FDA's Center for Drug Evaluation and Research (CDER)

10
New cards

What does the IND include?

results of pre-clinical testing and proposal for human testing

11
New cards

What is the goal of CDER?

to protect volunteers who participate in clinical trials from unreasonable and significant risk

12
New cards

What are the two possibilities of the result of CDER review?

-FDA indicates proposed clinical studies are safe to proceed

-FDA issuance of "clinical hold" - no clinical studies can be conducted

13
New cards

What is phase 1 of clinical trials?

the first time humans take the drug

14
New cards

How many people are normally in phase 1 of clinical trials?

20-100

15
New cards

In Phase 1, are the volunteers usually healthy or not healthy?

healthy

16
New cards

What are the three things we're looking for in phase 1 of clinical trials?

-is the drug safe?

-what are the side effects?

-How does the drug work in the body?

17
New cards

What are pharmacodynamics?

what a drug does to the body

18
New cards

What is pharmacokinetics?

what the body does to a drug

19
New cards

What percent of drugs move on to phase 2?

around 60%

20
New cards

How many volunteers enter phase 2 of clinical trials?

100-500

21
New cards

What is the purpose of phase 2?

-is the drug safe?

-how effective is the drug?

-how much drug should be taken, how often?

22
New cards

What is the main purpose of phase 2?

to test effectiveness

23
New cards

What is an indication?

-for the treatment, prevention, mitigation, cure, or diagnosis

of a disease or condition in age group

24
New cards

How many drugs make it to phase 3 of clinical trials?

around 60%

25
New cards

What are the goals of phase 3 of clinical trials?

-is the drug safe?

-how effective is the drug?

-is there a benefit or risk to a specific population?

26
New cards

What is the most expensive phase of clinical trials?

phase 3

27
New cards

What is the biggest goal of phase 3?

asking how it compares to another drug

28
New cards

What happens after phase 3 of clinical trials?

NDA or BLA

29
New cards

What does the manufacturer submit after phase 3?

-new drug application (NDA) for conventional/chemical drugs

-Biologics license Application (BLA) for therapeutic biologics

30
New cards

What does CDER do?

-review all human and animal data, including adverse effects that occurred during clinical trials

-review drug labeling-- some labeling is intended for HCPs and some for patients

31
New cards

What is phase 4 of clinical trials?

post marketing surveillance

32
New cards

What are the objectives of phase 4 studies?

study the drug's safety and effectiveness in real life scenarios to study long-term risks and benefits

-discover any side effects that did not show up in clinical trials

33
New cards

How does a new indication for approval come about?

the manufacturer must submit a supplemental new drug application (sNDA)

34
New cards

What phases need to be conducted for the approval of a new indication?

phase 2 and phase 3

35
New cards

Is a prescriber acting within the law to write for a use that is not an indication?

yes, as long as there is reasonable scientific evidence that the drug is effective for that use